169 related articles for article (PubMed ID: 37746066)
1. Effect of far-infrared radiation therapy on von Willebrand factor in patients with chronic kidney disease.
Yen CC; Hsu PC; Lin CC; Chen SC; Hsiao CY; Hwang SJ
Front Med (Lausanne); 2023; 10():1268212. PubMed ID: 37746066
[TBL] [Abstract][Full Text] [Related]
2. Plasma von Willebrand Factor and a Disintegrin and Metalloproteinase with Eight Thrombospondin-type 1 Motif Levels in Hemodialysis Patients: Relation to Vascular Access Thrombosis.
Elzorkany KMA; Montaser BAM; El-Hefnawy SM
Indian J Nephrol; 2018; 28(4):278-282. PubMed ID: 30158745
[TBL] [Abstract][Full Text] [Related]
3. Levels and activities of von Willebrand factor and metalloproteinase with thrombospondin type-1 motif, number 13 in inflammatory bowel diseases.
Cibor D; Owczarek D; Butenas S; Salapa K; Mach T; Undas A
World J Gastroenterol; 2017 Jul; 23(26):4796-4805. PubMed ID: 28765701
[TBL] [Abstract][Full Text] [Related]
4. The Intriguing Relationships of von Willebrand Factor, ADAMTS13 and Cardiac Disease.
Reardon B; Pasalic L; Favaloro EJ
J Cardiovasc Dev Dis; 2021 Sep; 8(9):. PubMed ID: 34564132
[TBL] [Abstract][Full Text] [Related]
5. Oxidation of Met1606 in von Willebrand factor is a risk factor for thrombotic and septic complications in chronic renal failure.
De Filippis V; Lancellotti S; Maset F; Spolaore B; Pozzi N; Gambaro G; Oggianu L; Calò LA; De Cristofaro R
Biochem J; 2012 Mar; 442(2):423-32. PubMed ID: 22091998
[TBL] [Abstract][Full Text] [Related]
6. ADAMTS13 Retards Progression of Diabetic Nephropathy by Inhibiting Intrarenal Thrombosis in Mice.
Dhanesha N; Doddapattar P; Chorawala MR; Nayak MK; Kokame K; Staber JM; Lentz SR; Chauhan AK
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1332-1338. PubMed ID: 28495930
[TBL] [Abstract][Full Text] [Related]
7. Von Willebrand factor, ADAMTS13 activity, TNF-α and their relationships in patients with chronic kidney disease.
Shen L; Lu G; Dong N; Jiang L; Ma Z; Ruan C
Exp Ther Med; 2012 Mar; 3(3):530-534. PubMed ID: 22969924
[TBL] [Abstract][Full Text] [Related]
8. Association of the von Willebrand Factor-ADAMTS13 Ratio With Incident Cardiovascular Events in Patients With Peripheral Arterial Disease.
Green D; Tian L; Greenland P; Liu K; Kibbe M; Tracy R; Shah S; Wilkins JT; Huffman MD; Liao Y; Lloyd Jones D; McDermott MM
Clin Appl Thromb Hemost; 2017 Oct; 23(7):807-813. PubMed ID: 27317583
[TBL] [Abstract][Full Text] [Related]
9. Effect of Vitamin D Status on Von Willebrand Factor and ADAMTS13 in Diabetic Patients on Chronic Hemodialysis.
Cohen-Hagai K; Rashid G; Einbinder Y; Ohana M; Benchetrit S; Zitman-Gal T
Ann Lab Med; 2017 Mar; 37(2):155-158. PubMed ID: 28029003
[TBL] [Abstract][Full Text] [Related]
10. Acute hemodynamic changes during far infrared treatment of the arteriovenous fistula in hemodialysis patients.
Hansen EK; Lindhard K; Hansen D
J Vasc Access; 2023 Jul; 24(4):739-746. PubMed ID: 34715757
[TBL] [Abstract][Full Text] [Related]
11. Far-infrared therapy: a novel treatment to improve access blood flow and unassisted patency of arteriovenous fistula in hemodialysis patients.
Lin CC; Chang CF; Lai MY; Chen TW; Lee PC; Yang WC
J Am Soc Nephrol; 2007 Mar; 18(3):985-92. PubMed ID: 17267744
[TBL] [Abstract][Full Text] [Related]
12. Higher and lower active circulating VWF levels: different facets of von Willebrand disease.
Casonato A; Pontara E; Morpurgo M; Sartorello F; De Groot PG; Cattini MG; Daidone V; De Marco L
Br J Haematol; 2015 Dec; 171(5):845-53. PubMed ID: 26456374
[TBL] [Abstract][Full Text] [Related]
13. Post-angioplasty far infrared radiation therapy improves 1-year angioplasty-free hemodialysis access patency of recurrent obstructive lesions.
Lai CC; Fang HC; Mar GY; Liou JC; Tseng CJ; Liu CP
Eur J Vasc Endovasc Surg; 2013 Dec; 46(6):726-32. PubMed ID: 24119468
[TBL] [Abstract][Full Text] [Related]
14. Decreased von Willebrand factor ristocetin cofactor activity and increased ADAMTS13 antigen increase postoperative drainage after coronary artery bypass grafting.
Mazur P; Plicner D; Zdziarska J; Sadowski J; Undas A
Eur J Cardiothorac Surg; 2014 Feb; 45(2):e26-32. PubMed ID: 24351199
[TBL] [Abstract][Full Text] [Related]
15. Von Willebrand Factor, ADAMTS13, and the Risk of Mortality: The Rotterdam Study.
Sonneveld MA; Franco OH; Ikram MA; Hofman A; Kavousi M; de Maat MP; Leebeek FW
Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2446-2451. PubMed ID: 27737864
[TBL] [Abstract][Full Text] [Related]
16. ADAMTS13 and Von Willebrand factor in patients undergoing hemodialysis.
Rios DR; Carvalho MG; Figueiredo RC; Ferreira CN; Rodrigues VL; Souza RA; e Silva AC; Fernandes AP; Gomes KB; Dusse LM
J Thromb Thrombolysis; 2012 Jul; 34(1):73-8. PubMed ID: 22298244
[TBL] [Abstract][Full Text] [Related]
17. An Overview of Laboratory Testing for ADAMTS13.
Favaloro EJ; Pasalic L
Methods Mol Biol; 2023; 2663():481-486. PubMed ID: 37204731
[TBL] [Abstract][Full Text] [Related]
18. Length polymorphisms of heme oxygenase-1 determine the effect of far-infrared therapy on the function of arteriovenous fistula in hemodialysis patients: a novel physicogenomic study.
Lin CC; Chung MY; Yang WC; Lin SJ; Lee PC
Nephrol Dial Transplant; 2013 May; 28(5):1284-93. PubMed ID: 23345623
[TBL] [Abstract][Full Text] [Related]
19. Effects of far infrared therapy on arteriovenous fistulas in hemodialysis patients: a meta-analysis.
Wan Q; Yang S; Li L; Chu F
Ren Fail; 2017 Nov; 39(1):613-622. PubMed ID: 28805538
[TBL] [Abstract][Full Text] [Related]
20. Relationship between ABO blood groups and von Willebrand factor, ADAMTS13 and factor VIII in patients undergoing hemodialysis.
Rios DR; Fernandes AP; Figueiredo RC; Guimarães DA; Ferreira CN; Simões E Silva AC; Carvalho MG; Gomes KB; Dusse LM
J Thromb Thrombolysis; 2012 May; 33(4):416-21. PubMed ID: 22466813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
